1. What data in particular will be shared?
   Response - All of the individual participant data collected during the trial, after de-identification.
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Informed Consent Form
   Response - Clinical Study Report
   Response -  Analytic Code
   
   
3. Who will be able to view these files?
   Response - Anyone
   


4. For what types of analyses will this data be available?
   Response - Any purpose.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [klakshmimanogna@gmail.com].
   


6. For how long will this data be available start date provided 25-12-2026 and end date provided 31-12-2100?
   Response - Immediately following publication. No end date.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - Nil

The Vatashtheela Mutraghata reflects the symptoms of urine retention, incomplete voiding, dribbling, hesitancy, dysuria, straining during urination etc. These are feature of Lower Urinary Tract Symptoms and can be co–related with Benign Prostatic Hyperplasia in modern parlance. Being prostatic hyperplasia is one of the most prevalent obstructive uropathy of advanced age group people above the incidence has been estimated that 5-10% of men at their age of 40 have Prostatic enlargement & 80% by their age of 80 have evidence of BPH. Clinical features of BPH are hesitancy, dysuria, frequency, urgency, haematuria, pain, retention of urine renal failure, prostatism stream of urine, straining during micturition etc. and often features of acute or chronic retention of urine and uraemia also occurs during progression of disease.

Much advancement both technical and surgical nature have come into existence but still satisfactory treatment of the problemis not found in the modern surgery and urology. The methods like TURP (Trans Urethral Resection of Prostate), TUNA (Trans Urethral Needle Ablation), TUMT (Trans Urethral Microwave Thermotherapy), High-intensity focused ultrasound, TUE(Trans Urethral Electro vaporization, water induced thermotherapy and prostatic stent insertion are in practice but still not comprehensive.

In Ayurveda elaborated description regarding the management of Astheela is found across the samhitas and later works of medieval and modern period of Ayurveda. As discussed earlier the main cause for formation of the disease is Vatadosha, which is either in vridhiavastha or in avrutaavastha, Other contributory doshas are kapha and pitta.

The major chikista sutra formulated for these conditions includes the measures of pacifying Vata like Avagahaswedam, Uttaravasti and other procedures causing the Vatanulomanam. There are many drugs and compounds known to have good effect on Prosate and its pathology.

 Benign Prostatic Hyperplasia is a condition which left untreated may lead to acute urinary retention, urinary tract infections, renal failure in due course of time. In modern system of medicines, Benign Prostatic Hyperplasia is managed with both conservative and surgical treatment modalities, but they are too expensive. The surgical correction also has potential complications including stricture of urethra, incontinence of urine. In Ayurveda, the management of Benign Prostatic Hyperplasia is done by adopting the principles of mutrakrcchra and mutraghata chikitsa,mutravegadharanajanya vikara cikitsa and granthi cikitsa which include avapidaka snehapana, vasti, ksara prayoga.

Thus the present study is entilted as  A CLINICAL EVALUATION OF USHEERADYA TAILAM UTTARBASTI THE MANAGEMENT OF MUTRAGHATA (BPH)